We are live on ! Find out more
MIRA icon

MIRA Pharmaceuticals
MIRA

29 hedge funds and large institutions have $1.89M invested in MIRA Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

800% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 1

56% more capital invested

Capital invested by funds: $1.21M → $1.89M (+$682K)

45% more funds holding

Funds holding: 20 → 29 (+9)

1.41% more ownership

Funds ownership: 5.91% → 7.32% (+1.4%)

Holders
29
Holders Change
+9
Holders Change %
+45%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$159K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$125K
3
Renaissance Technologies
Renaissance Technologies
New York
+$67.8K
4
Northern Trust
Northern Trust
Illinois
+$43.7K
5
FAB
First American Bank
Illinois
+$43.5K

Top Sellers

Rank Fund Capital Flow
1
FFO
Fortitude Family Office
Arizona
-$935
2
UBS Group
UBS Group
Switzerland
-$412
Name Holding Trade Value Shares
Change 		Change in
Stake
CSI
1
Cross Staff Investments
New York
$489K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$277K +$125K +85,819 +73%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$186K +$1.66K +1,145 +0.8%
BlackRock
4
BlackRock
New York
$149K +$159K +109,769 New
SEM
5
Suncoast Equity Management
Florida
$140K – – –
FAB
6
First American Bank
Illinois
$68K +$43.5K +30,000 +150%
State Street
7
State Street
Massachusetts
$66.8K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$63.5K +$67.8K +46,700 New
Two Sigma Investments
9
Two Sigma Investments
New York
$62.2K +$37.5K +25,816 +130%
JWCA
10
J.W. Cole Advisors
Florida
$61.9K +$7.03K +4,846 +12%
Northern Trust
11
Northern Trust
Illinois
$59.5K +$43.7K +30,137 +222%
XT
12
XTX Topco
Cayman Islands
$48.9K +$20.4K +14,050 +64%
IAIM
13
International Assets Investment Management
Florida
$42.4K – – –
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$41K +$759 +523 +2%
Creative Planning
15
Creative Planning
Kansas
$30.7K – – –
AQR Capital Management
16
AQR Capital Management
Connecticut
$29.9K +$31.9K +22,000 New
Mariner
17
Mariner
Kansas
$22.4K – – –
VF
18
Virtu Financial
New York
$17K +$17.7K +12,196 New
CSP
19
Cary Street Partners
Virginia
$13.6K – – –
FDCDDQ
20
Federation des caisses Desjardins du Quebec
Quebec, Canada
$9.52K +$10.2K +7,000 New
Citigroup
21
Citigroup
New York
$5.2K +$5.54K +3,820 New
Osaic Holdings
22
Osaic Holdings
Arizona
$2.74K – – –
SPIA
23
Steward Partners Investment Advisory
New York
$2.72K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$2.44K +$2.61K +1,797 New
EWA
25
EverSource Wealth Advisors
Alabama
$496 +$530 +365 New
1
2

MIRA Hedge Fund Activity: Q3 2025 in Review

29 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q3 2025, worth a combined $1.89M — up 56% from $1.21M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MIRA positions and 1 closed out — a net gain of 9 holders — while 9 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $159K. The largest seller was Fortitude Family Office, exiting entirely with an estimated $935 sold.

  • 29 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q3 2025, up from 20 in Q2 2025.
  • Funds reported $1.89M of MIRA Pharmaceuticals stock for Q3 2025, up 56% quarter-over-quarter.
  • 10 funds opened new MIRA Pharmaceuticals positions in Q3 2025 and 1 closed out, a net change of +9 holders.
  • The largest MIRA Pharmaceuticals buyer in Q3 2025 was BlackRock, an estimated $159K added.
  • The largest MIRA Pharmaceuticals seller in Q3 2025 was Fortitude Family Office, an estimated $935 sold.

Based on aggregated 13F filings for Q3 2025.